N-Carbethoxy-4-piperidone | CAS:29976-53-2

We serve N-Carbethoxy-4-piperidone CAS:29976-53-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
N-Carbethoxy-4-piperidone

Chemical Name:N-Carbethoxy-4-piperidone
CAS.NO:29976-53-2
Synonyms:N-Carbethoxy-4-piperidone
Ethyl 4-oxo-1-piperidinecarboxylate
1-CARBETHOXY-4-PIPERIDONE
N-Ethoxycarbonyl-4-piperidinone
1-Ethoxycarbonyl-4-piperidinone
ethyl 4-oxopiperidine-1-carboxylate
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 273.4±33.0 °C at 760 mmHg
Molecular Formula C8H13NO3
Molecular Weight 171.194
Flash Point 87.8±0.0 °C
 
Specification:
Appearance:Light yellow liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Domperidone、Cisapride and Loperamide hydrochloride.



Contact us for information like N-Carbethoxy-4-piperidone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 4-oxopiperidine-1-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-CARBETHOXY-4-PIPERIDONE Use and application,1-Ethoxycarbonyl-4-piperidinone technical grade,usp/ep/jp grade.


Related News: An active pharmaceutical ingredient (API) is a substance, or a mixture of ingredients, combined in the manufacture of a pharmaceutical or drug.1,2,4-triazole-1-carboximidamide,hydrochloride manufacturer We partner with life science companies of all sizes, drawing on over 20 years of industry experience.2-Chloro-3,5-dibromopyridine supplier We partner with life science companies of all sizes, drawing on over 20 years of industry experience.4-methoxycarbonyl-3-nitrobenzoic acid vendor With the death toll surging past 300 and 14,300 cases confirmed, authorities across the country have activated the highest public health emergency response, stepping up screening of arrivals from Wuhan.The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses.